|
|
||||||||
Journal of Lipid Research, Vol 26, 288-297, Copyright © 1985 by Lipid Research, Inc.
AA Spector, AM Scanu, TL Kaduce, PH Figard, GM Fless and RL Czervionke
Prostacyclin (PGI2) production by bovine aortic or human umbilical vein
endothelial cells increased when either human high density lipoproteins3
(HDL3) or low density lipoproteins (LDL) were added to a serum-free culture
medium. At low concentrations and short incubation times, HDL3 produced
more PGI2 than LDL, but LDL was just as effective as HDL3 in 18-hr
incubations with high concentrations of lipoproteins. Neither lipoprotein
was toxic to the cultures as assessed by [3H]leucine incorporation into
cell protein. The stimulatory effect of HDL3 and LDL on PGI2 production
decreased as growing cultures became confluent. Incubation with
lipoproteins neither enhanced arachidonic acid release nor increased PGI2
formation when the cells were stimulated subsequently with ionophore
A23187, indicating that the lipoproteins do not affect the intracellular
processes involved in PGI2 production. The addition of albumin reduced the
amount of PGI2 formation elicited by HDL3 or LDL. As compared with
albumin-bound arachidonic acid, from 6- to 13-fold less PGI2 was produced
during incubation with the lipoproteins. Furthermore, the amount of PGI2
formation elicited by the lipoproteins in 18 hr was 4-fold less than that
produced during incubation with a fatty acid mixture containing only 5%
arachidonic acid, and 3-fold less than when the cells were stimulated with
the ionophore A23187 for 20 min. Taken together, our results indicate that
human HDL and LDL contribute to endothelial PGI2 production only in a
modest way and suggest that this process is not specific for either of
these two plasma lipoproteins. In view of the greater participation of
albumin-bound arachidonic acid in PGI2 production, plasma lipoproteins may
not play as important a role in endothelial prostaglandin formation as has
been suggested.
ARTICLES
Effect of human plasma lipoproteins on prostacyclin production by cultured endothelial cells
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. Mineo, H. Deguchi, J. H. Griffin, and P. W. Shaul Endothelial and Antithrombotic Actions of HDL Circ. Res., June 9, 2006; 98(11): 1352 - 1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Calabresi, M. Gomaraschi, and G. Franceschini Endothelial Protection by High-Density Lipoproteins: From Bench to Bedside Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1724 - 1731. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. O'Connell and J. Genest Jr High-Density Lipoproteins and Endothelial Function Circulation, October 16, 2001; 104(16): 1978 - 1983. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lamarche, S. Moorjani, B. Cantin, G. R. Dagenais, P. J. Lupien, and J.-P. Despres Associations of HDL2 and HDL3 Subfractions With Ischemic Heart Disease in Men: Prospective Results From the Quebec Cardiovascular Study Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1098 - 1105. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |